
Randy Citrin Shay
Examiner (ID: 19048)
| Most Active Art Unit | 3308 |
| Art Unit(s) | 3305, 3738, 2899, 3774, 3308 |
| Total Applications | 911 |
| Issued Applications | 669 |
| Pending Applications | 28 |
| Abandoned Applications | 214 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10214903
[patent_doc_number] => 20150099895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'DIALLYL ETHERS OF 2,5BIS(HYDROXYMETHYL)TETRAHYDROFURAN AND PROCESSES FOR MAKING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/401199
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2457
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401199
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/401199 | Diallyl ethers of 2,5bis(hydroxymethyl)tetrahydrofuran and processes for making the same | Jun 9, 2013 | Issued |
Array
(
[id] => 11879603
[patent_doc_number] => 09750758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Compositions and methods for treating cancer with aberrant lipogenic signaling'
[patent_app_type] => utility
[patent_app_number] => 14/410352
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 26054
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410352
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/410352 | Compositions and methods for treating cancer with aberrant lipogenic signaling | Jun 9, 2013 | Issued |
Array
(
[id] => 9108164
[patent_doc_number] => 20130281296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Compunds and processes that generate cyclopropenes and substituted cyclopropenes on demand'
[patent_app_type] => utility
[patent_app_number] => 13/986772
[patent_app_country] => US
[patent_app_date] => 2013-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5825
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13986772
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/986772 | Compunds and processes that generate cyclopropenes and substituted cyclopropenes on demand | Jun 3, 2013 | Abandoned |
Array
(
[id] => 10165611
[patent_doc_number] => 09196844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-24
[patent_title] => 'Method of synthesizing pyrazine derivative, and light-emitting element, light-emitting device, electronic device, and lighting device'
[patent_app_type] => utility
[patent_app_number] => 13/905829
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 18721
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905829
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/905829 | Method of synthesizing pyrazine derivative, and light-emitting element, light-emitting device, electronic device, and lighting device | May 29, 2013 | Issued |
Array
(
[id] => 9069550
[patent_doc_number] => 20130261306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'PREPARATION OF C-PYRAZINE-METHYLAMINES'
[patent_app_type] => utility
[patent_app_number] => 13/901054
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5965
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901054
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/901054 | PREPARATION OF C-PYRAZINE-METHYLAMINES | May 22, 2013 | Abandoned |
Array
(
[id] => 10422434
[patent_doc_number] => 20150307446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCOSITIS'
[patent_app_type] => utility
[patent_app_number] => 14/533131
[patent_app_country] => US
[patent_app_date] => 2014-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9141
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14533131
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/533131 | Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis | May 18, 2013 | Issued |
Array
(
[id] => 10241494
[patent_doc_number] => 20150126489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'FUMIGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/399392
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10933
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399392
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399392 | Fumigillol compounds and methods of making and using same | May 7, 2013 | Issued |
Array
(
[id] => 10248541
[patent_doc_number] => 20150133537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => '3 - (1\' - ADAMANTYL) - 1 - AMINOMETHYL - 3, 4 - DIHYDRO - 5, 6 - DIHYDROXY - 1H - 2 - BENZOPYRAN FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH BETA-AMYLOID INDUCED TOXICITY'
[patent_app_type] => utility
[patent_app_number] => 14/395409
[patent_app_country] => US
[patent_app_date] => 2013-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7609
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395409
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/395409 | 3 - (1' - ADAMANTYL) - 1 - AMINOMETHYL - 3, 4 - DIHYDRO - 5, 6 - DIHYDROXY - 1H - 2 - BENZOPYRAN FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH BETA-AMYLOID INDUCED TOXICITY | Apr 17, 2013 | Abandoned |
Array
(
[id] => 10110002
[patent_doc_number] => 09145406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-29
[patent_title] => 'Process for preparing dasatinib monohydrate'
[patent_app_type] => utility
[patent_app_number] => 14/382557
[patent_app_country] => US
[patent_app_date] => 2013-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3874
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382557
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382557 | Process for preparing dasatinib monohydrate | Apr 15, 2013 | Issued |
Array
(
[id] => 11343468
[patent_doc_number] => 09527863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Thieno-indole moieties and methods of treating using the same'
[patent_app_type] => utility
[patent_app_number] => 14/390644
[patent_app_country] => US
[patent_app_date] => 2013-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 24256
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390644
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390644 | Thieno-indole moieties and methods of treating using the same | Mar 27, 2013 | Issued |
Array
(
[id] => 10898144
[patent_doc_number] => 08921358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-30
[patent_title] => 'Apoptosis signal-regulating kinase 1 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/852924
[patent_app_country] => US
[patent_app_date] => 2013-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 121104
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13852924
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/852924 | Apoptosis signal-regulating kinase 1 inhibitors | Mar 27, 2013 | Issued |
Array
(
[id] => 9711056
[patent_doc_number] => 08835627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid'
[patent_app_type] => utility
[patent_app_number] => 13/849798
[patent_app_country] => US
[patent_app_date] => 2013-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5595
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13849798
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/849798 | Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | Mar 24, 2013 | Issued |
Array
(
[id] => 8963096
[patent_doc_number] => 20130202698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'L-ORNIDAZOLE FORMULATIONS AND THEIR APPLICATIONS IN TREATMENT OF PARASITIC INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/831706
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15240
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13831706
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/831706 | L-ORNIDAZOLE FORMULATIONS AND THEIR APPLICATIONS IN TREATMENT OF PARASITIC INFECTIONS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9739872
[patent_doc_number] => 20140275590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS'
[patent_app_type] => utility
[patent_app_number] => 13/844379
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25371
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844379
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/844379 | Methods for the synthesis of sphingomyelins and dihydrosphingomyelins | Mar 14, 2013 | Issued |
Array
(
[id] => 10587944
[patent_doc_number] => 09309547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Methods for making tocoflexols and analogues thereof'
[patent_app_type] => utility
[patent_app_number] => 14/402792
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6369
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402792 | Methods for making tocoflexols and analogues thereof | Mar 12, 2013 | Issued |
Array
(
[id] => 9857244
[patent_doc_number] => 20150037261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'New Class Of Diazepine Derivative Chelating Agents And Complexes With Paramagnetic Metals Thereof As MRI Contrast Agents'
[patent_app_type] => utility
[patent_app_number] => 14/384414
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11859
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384414
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/384414 | Class of diazepine derivative chelating agents and complexes with paramagnetic metals thereof as MRI contrast agents | Mar 12, 2013 | Issued |
Array
(
[id] => 10134952
[patent_doc_number] => 09168260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-27
[patent_title] => 'Benzodiazepine compounds with anti-flavivirus activity'
[patent_app_type] => utility
[patent_app_number] => 14/380546
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 2630
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14380546
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/380546 | Benzodiazepine compounds with anti-flavivirus activity | Feb 21, 2013 | Issued |
Array
(
[id] => 9932269
[patent_doc_number] => 20150080461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'Composition Having Antiviral Activity against Flavivirus'
[patent_app_type] => utility
[patent_app_number] => 14/384373
[patent_app_country] => US
[patent_app_date] => 2013-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4267
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384373
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/384373 | Composition Having Antiviral Activity against Flavivirus | Jan 30, 2013 | Abandoned |
Array
(
[id] => 8950581
[patent_doc_number] => 20130196362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'DIARYLAMINE-BASED FLUOROGENIC PROBES FOR DETECTION OF PEROXYNITRITE'
[patent_app_type] => utility
[patent_app_number] => 13/754499
[patent_app_country] => US
[patent_app_date] => 2013-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22223
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13754499
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/754499 | Diarylamine-based fluorogenic probes for detection of peroxynitrite | Jan 29, 2013 | Issued |
Array
(
[id] => 8951290
[patent_doc_number] => 20130197071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'PRODUCTION OF LIPOXYGENASE INHIBITORS VIA FUNGAL BIOSYNTHETIC PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 13/752276
[patent_app_country] => US
[patent_app_date] => 2013-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7838
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13752276
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/752276 | PRODUCTION OF LIPOXYGENASE INHIBITORS VIA FUNGAL BIOSYNTHETIC PATHWAY | Jan 27, 2013 | Abandoned |